The phenotype of PGC-/MUC1-/MUC2+ may be a predictive biomarker for diagnosing MA or SRCC or distinguishing from tubular adenocarcinoma accompanied by mucinous secretion or signet ring cell scattered distribution. This evidence concerns the gene MUC1 and tubular adenocarcinoma.